Losartan Potassium
Product Images NDC 68151-0183

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68151-0183). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure01 (Figure01)

This appears to be a graph or chart showing the percentage of patients who achieved the primary endpoint in a study of two medications: Atenolol and Losartan potassium. It also includes an adjusted risk reduction percentage and the study duration in months.*

FDA Label Image

Figure02 (Figure02)

This text seems to be a chart or table showing the percentage of patients with fatal/non-fatal stroke for two different medications, Atenolol and Losartan potassium. The adjusted risk reduction is also provided, along with a p-value. The table also includes study months from 6 to 66. Without additional context or information, it is difficult to provide a more detailed description or analysis.*

FDA Label Image

Figure03 (Figure03)

This is a table displaying the results of a study comparing the effectiveness of Losartan K and Atenolol in treating stroke. The data is broken down by age group, gender, race, diabetes status, and history of CVD. The results indicate that Losartan K had a slight advantage over Atenolol in reducing the incidence of primary composite stroke (fatal and non-fatal). The data has been adjusted for baseline Framingham risk score and level of electrocardiographic eft ventricular hypertrophy.*

FDA Label Image

Figure04 (Figure04)

This is a table showing the risk reduction percentage of a drug called Losartan Potassium in comparison to a placebo. The risk reduction achieved by the drug is 16.1% with a significance level of 0.022. However, the context and the event being studied are not available.*

FDA Label Image

Label Image (Lbl681510183)

This is a description of a medication. The medication is listed as "Losartan Potassium," and is in tablet form with a strength of 50 mg. The manufacturer is Teva, and the lot number is LoT89L211. The expiration date is listed as November 2014. The packaging includes a code labeled as UB52914SN19 and a label indicating that it is for prescription use only. The remaining text is not legible due to possible errors.*

FDA Label Image

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.